ABBV logo

ABBV
Abbvie Inc

32,150
Mkt Cap
$405.63B
Volume
53.00
52W High
$244.81
52W Low
$164.39
PE Ratio
169.00
ABBV Fundamentals
Price
$223.98
Prev Close
$225.18
Open
$225.54
50D MA
$227.62
Beta
0.33
Avg. Volume
6.3M
EPS (Annual)
$2.39
P/B
-149.83
Rev/Employee
$1.02M
Loading...
Loading...
News
all
press releases
Alliancebernstein L.P. Increases Stake in AbbVie Inc. $ABBV
Alliancebernstein L.P. grew its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 28.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Top Pharmaceutical Stocks To Keep An Eye On - December 11th
Eli Lilly and Company, Novo Nordisk A/S, Pfizer, Regeneron Pharmaceuticals, AbbVie, AstraZeneca, and Abbott Laboratories are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...
MarketBeat·13h ago
News Placeholder
Is AbbVie Stock Too Cheap to Ignore at Today's Price?
Key PointsSome valuation metrics suggest that AbbVie is a cheap stock...
Nasdaq News: Markets·17h ago
News Placeholder
Botox maker quietly launches plan to fend off rivals
Botox has become so synonymous with anti-aging wrinkle treatments that many people use the name the same way they refer to tissues as Kleenex.But the brand power has a downside: Competitors have...
TheStreet.com·19h ago
News Placeholder
The Manufacturers Life Insurance Company Raises Stock Holdings in AbbVie Inc. $ABBV
The Manufacturers Life Insurance Company lifted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 8.9% in the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·20h ago
News Placeholder
Glenview Trust co Has $78.24 Million Stock Holdings in AbbVie Inc. $ABBV
Glenview Trust co raised its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 2.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·20h ago
News Placeholder
Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth
ABBV's expanding oncology lineup, spanning new solid tumor drugs and rising Venclexta sales, is helping drive steady top-line growth.
Zacks·21h ago
News Placeholder
AbbVie (NYSE:ABBV) Raised to "Strong-Buy" at Hsbc Global Res
Hsbc Global Res raised shares of AbbVie from a "hold" rating to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·22h ago
News Placeholder
CIBC Asset Management Inc Has $59.11 Million Stock Holdings in AbbVie Inc. $ABBV
CIBC Asset Management Inc decreased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 5.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·24h ago
News Placeholder
Pharmaceutical Stocks To Follow Today - December 10th
Eli Lilly and Company, AbbVie, Pfizer, Novo Nordisk A/S, and Terns Pharmaceuticals are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical...
MarketBeat·2d ago

Latest ABBV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.